Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Nutritional Intervention in Children With Autism Using Whey Protein (Immunocal): Impact on Core Areas of Behavior

ClinicalTrials.gov ID: NCT01366859

Public ClinicalTrials.gov record NCT01366859. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Nutritional Intervention Using Supplementation With Cysteine-Rich Whey Protein Isolate (Immunocal®) in Children With Autism: Effects in Core Areas of Behavior- A Randomized Double-Blind Study

Study identification

NCT ID
NCT01366859
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Nova Southeastern University
Other
Enrollment
81 participants

Conditions and interventions

Interventions

  • Whey Protein Dietary Supplement
  • Rice Protein (Placebo) Dietary Supplement

Dietary Supplement

Eligibility (public fields only)

Age range
3 Years to 5 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2011
Primary completion
Sep 30, 2016
Completion
Sep 30, 2016
Last update posted
Nov 2, 2016

2011 – 2016

United States locations

U.S. sites
3
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Mailman Segal Center Fort Lauderdale Florida 33314
Nova Southeastern University Clinic Fort Lauderdale Florida 33328
Nova Southeastern University, College of Pharmacy Fort Lauderdale Florida 33328

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01366859, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 2, 2016 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01366859 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →